EMX Royalty Corporation(NYSE MKT:EMX) 
EMX Royalty Corporation engages in the acquisition, exploration, and evaluation of metals and mineral properties. It explores for gold, silver, platinum, palladium, copper, lead, zinc, nickel, cobalt, volcanogenic massive sulfide, molybdenum, and iron deposits. The company's royalty and exploration ...
Website: http://www.emxroyalty.com
Full Time Employees: 40
Sector: Basic Materials
Industry: Other Industrial Metals & Mining
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2016-09-30 | 2016-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue and other income | 6,239 | 8,422 | 7,027 | 6,005 | 6,240 | 12,925,000 | 3,408,000 | 1,749,000 | 9,338,000 | 8,952,000 | 1,298,000 | 1,504 | 4,255,000 | 751,000 | 1,261 | 2,350 | 751 | 1,212 | 1,074 | 1,415 | |||
costs and expenses | |||||||||||||||||||||||
general and administrative | 1,616 | 2,170 | 1,537 | 1,694 | 2,148 | 1,230,000 | 1,332,000 | 2,122,000 | 1,644,000 | 1,166,000 | 1,851,000 | 979,000 | 1,203,000 | ||||||||||
royalty generation and project evaluation | 2,176 | 2,502 | 3,090 | 2,907 | 2,934 | ||||||||||||||||||
depletion, depreciation, and direct royalty taxes | 1,063 | 2,329 | 2,230 | 1,369 | 2,419 | 1,595,000 | 790,000 | 494,000 | 3,250,000 | 947,000 | 266,000 | 260,000 | 398,000 | ||||||||||
share-based payments | 409 | 882 | 321 | 872 | 177 | 1,038,000 | 122,000 | 494,000 | 481,000 | 1,610,000 | 542,000 | 1,206 | 1,366,000 | 78,000 | 14 | 1,448 | 78 | 114 | 908 | 13,731 | |||
income from operations | 975 | 539 | -151 | -837 | -1,438 | 5,433,000 | 1,311,000 | 1,285,000 | |||||||||||||||
yoy | -167.80% | -99.99% | -100.11% | 322.80% | |||||||||||||||||||
qoq | 80.89% | -456.95% | -81.96% | -41.79% | -100.03% | 2.02% | |||||||||||||||||
gain on revaluation of investments | 720 | 746 | 1,778 | 1,142 | 84 | 4,997,000 | |||||||||||||||||
loss on sale of marketable securities | -550 | -346 | -1,535 | -411 | |||||||||||||||||||
loss on revaluation of derivative liabilities | -400 | -162 | -41 | ||||||||||||||||||||
equity income from investment in slm california | 1,334 | 1,680 | |||||||||||||||||||||
foreign exchange gain | 413 | 207 | 51 | 5,419,000 | 105,068 | ||||||||||||||||||
impairment charges | -635 | -101 | -45 | -43,000 | |||||||||||||||||||
gain on revaluation of receivables | 176 | ||||||||||||||||||||||
finance expense | -516 | -681 | -921 | -1,080 | -1,065 | -1,298,000 | |||||||||||||||||
other losses | -31 | -2,326 | |||||||||||||||||||||
income before income taxes | 1,486 | 1,882 | 1,226 | -3,430 | -2,235 | 4,517,000 | 22,807,000 | 4,210,662 | |||||||||||||||
deferred income tax expense | -93 | -62 | -165 | -1,890,000 | |||||||||||||||||||
income tax expense | -751 | -539 | -427 | -147 | -184,000 | ||||||||||||||||||
income for the period | 642 | 1,260 | 1,194 | 2,443,000 | 18,592,000 | 2,120,000 | 4,732,192 | ||||||||||||||||
basic income per share | 0.01 | 0.01 | 0.01 | ||||||||||||||||||||
diluted income per share | 0.01 | 0.01 | 0.01 | ||||||||||||||||||||
weighted-average no. of shares outstanding - basic | 108,712,259 | 109,294,071 | 114,240,974 | 113,076,261 | 112,252,502 | 111,021,550 | 110,698,311 | 110,091,728 | 108,890,140 | 84,891,451 | 82,789,474 | 79,979,320 | |||||||||||
weighted-average no. of shares outstanding - diluted | 109,272,204 | 109,426,413 | 114,265,684 | 113,076,261 | 112,252,502 | 111,437,211 | 110,698,311 | 110,091,728 | 108,890,140 | 84,891,451 | 94,060,613 | 80,653,474 | |||||||||||
deferred income tax recovery | -83 | 155 | 248,000 | 521,530 | 378,238 | ||||||||||||||||||
gain on sale of marketable securities | -307 | 39,000 | 441,000 | 47,000 | |||||||||||||||||||
gain on revaluation of derivative liabilities | 283 | -66 | 336,000 | 188,000 | |||||||||||||||||||
equity income from investment in associated entity | 1,276 | 1,411 | 797 | 732,000 | 1,340,000 | ||||||||||||||||||
loss on debt settlement | -783 | ||||||||||||||||||||||
loss on revaluation of receivables | |||||||||||||||||||||||
income tax recovery | 30 | 100,000 | |||||||||||||||||||||
foreign exchange loss | -139 | -116 | -399,000 | ||||||||||||||||||||
loss for the period | -4,022 | -2,227 | |||||||||||||||||||||
basic loss per share | -0.04 | -0.02 | |||||||||||||||||||||
diluted loss per share | -0.04 | -0.02 | |||||||||||||||||||||
royalty generation costs | 3,629,000 | 2,444,000 | 2,652,000 | 3,944,000 | |||||||||||||||||||
loss on revaluation of investments | -160,000 | ||||||||||||||||||||||
gain on debt and receivable modifications | -123,000 | 124,000 | |||||||||||||||||||||
settlement gain | 18,825,000 | ||||||||||||||||||||||
basic earnings per share | 0.02 | 0.18 | 0.03 | 0.03 | |||||||||||||||||||
diluted earnings per share | 0.02 | 0.17 | 0.02 | 0.02 | |||||||||||||||||||
project and royalty generation costs | 2,134,000 | 1,287,000 | 3,689,000 | 1,600,000 | |||||||||||||||||||
equity income from investments in associated entities | 911,000 | 2,667,000 | 221,000 | ||||||||||||||||||||
gain on debt modification | 4,005,000 | ||||||||||||||||||||||
weighted-average number of common shares outstanding - basic | 105,382,744 | ||||||||||||||||||||||
weighted-average number of common shares outstanding - diluted | 107,282,369 | ||||||||||||||||||||||
finance expenses and other | |||||||||||||||||||||||
royalty revenue | 883,000 | 352,000 | 296,000 | 343,000 | 630,000 | 392,000 | |||||||||||||||||
interest income | 368,000 | 424,000 | 54,000 | 255,000 | 343,000 | 524,000 | |||||||||||||||||
option and other property income | 253,000 | 463,000 | 1,938,000 | 153,000 | |||||||||||||||||||
dividend income | 22,000 | 62,000 | |||||||||||||||||||||
in thousands of dollars | |||||||||||||||||||||||
general and administrative expenses | |||||||||||||||||||||||
salaries, consultants, and benefits | 774,000 | 479,000 | 783,000 | 473,000 | 492,000 | 370,000 | 373,000 | ||||||||||||||||
professional fees | 523,000 | 228,000 | 263,000 | 232,000 | 269,000 | 374,000 | 71,000 | 187,081 | 153,535 | ||||||||||||||
investor relations and shareholder information | 193,000 | 183,000 | 124,000 | 160,000 | 201,000 | 133,000 | 228,000 | 55,578 | 40,644 | ||||||||||||||
transfer agent and filing fees | 39,000 | 118,000 | 31,000 | 56,000 | 12,000 | 54,000 | 106,000 | 17,244 | 13,702 | ||||||||||||||
administrative and office | 266,000 | 247,000 | 215,000 | 267,000 | 234,000 | 250,000 | 228,000 | 158,288 | 192,863 | ||||||||||||||
travel | 12,000 | 14,000 | 38,000 | 15,000 | 34,000 | 93,000 | 45,000 | 6,446 | 10,609 | ||||||||||||||
in thousands of dollars, except per share amounts | |||||||||||||||||||||||
fiscal quarter ended | |||||||||||||||||||||||
recoveries from partners | 1,792 | 3,374 | 1,721 | 517 | 1,714 | 1,669 | 788 | ||||||||||||||||
net income for the period | 2,120 | ||||||||||||||||||||||
change in fair value of fair value through profit or loss assets | |||||||||||||||||||||||
equity gain from investment in associate | 158,000 | ||||||||||||||||||||||
write-off of other property interests | |||||||||||||||||||||||
basic and diluted loss per share | |||||||||||||||||||||||
weighted-average no. of shares outstanding - basic and diluted | 85,570,090 | ||||||||||||||||||||||
other comprehensive income | |||||||||||||||||||||||
change in fair value of financial instruments | |||||||||||||||||||||||
currency translation adjustment | |||||||||||||||||||||||
comprehensive loss for the period | |||||||||||||||||||||||
equity income from investment in associate | |||||||||||||||||||||||
general and administrative expenses for the three | |||||||||||||||||||||||
months ended | 2,019,000 | ||||||||||||||||||||||
general and administrative expenses for the three months ended | |||||||||||||||||||||||
optioned property and other property income | 239,000 | 158,000 | |||||||||||||||||||||
loss on sale of projects | |||||||||||||||||||||||
- | |||||||||||||||||||||||
royalty income | 751,326 | 373,266 | |||||||||||||||||||||
cost of sales | |||||||||||||||||||||||
gold tax | |||||||||||||||||||||||
depletion | |||||||||||||||||||||||
net royalty income | 28,936 | ||||||||||||||||||||||
exploration expenditures | 1,566,049 | 1,300,154 | |||||||||||||||||||||
less: recoveries | |||||||||||||||||||||||
net exploration expenditures | 1,318,080 | 1,138,040 | |||||||||||||||||||||
depreciation | 28,622 | 28,622 | |||||||||||||||||||||
salaries and consultants | 196,212 | 345,080 | |||||||||||||||||||||
total general and administrative expenses | 649,471 | 798,786 | |||||||||||||||||||||
change in fair value of fair value through profit or loss investments | 162,782 | ||||||||||||||||||||||
gain on sale of exploration and evaluation assets | 6,648,569 | ||||||||||||||||||||||
equity loss in associated companies | |||||||||||||||||||||||
realized loss on sale of investments | |||||||||||||||||||||||
interest income and other | 42,802 | ||||||||||||||||||||||
writedown of goodwill | |||||||||||||||||||||||
basic and diluted income per share | 0.06 | ||||||||||||||||||||||
weighted-average number of common shares outstanding | 73,951,176 | 73,568,244 | |||||||||||||||||||||
change in fair value of fair value throught profit or loss investments | 259,795 | ||||||||||||||||||||||
gain on acquisition and sale of exploration and evaluation assets | |||||||||||||||||||||||
other | 24,486 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2015-12-31 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-08-15 | 2014-03-31 | 2013-09-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 17,158 | 19,215 | 21,673 | 21,421 | 18,805 | 14,297,000 | 9,862,000 | 44,970,000 | 46,735,000 | 41,979,000 | 49,200,000 | 55,627,000 | 58,194,000 | 66,367,000 | 74,089,000 | 75,515,000 | 77,750,000 | 86,175,331 | 6,919,867 | 2,253,136 | 5,132,291 | 6,293,745 | 8,154,167 | 3,199,686 | 3,787,616 | 2,381,957 | 5,634,601 | 2,126,061 | 4,059,948 | 6,450,308 | 9,688,653 | 11,417,684 | 13,137,110 | 19,937,115 | 26,127,856 | 34,712,528 | |||
investments | 6,745 | 6,710 | 6,695 | 4,943 | 5,343 | 8,479,000 | 9,536,000 | 10,267,000 | 13,651,000 | 20,583,000 | 22,808,000 | 16,418,000 | 19,026,000 | 15,720,000 | 13,250,000 | 9,576,000 | 4,208,000 | 3,831,000 | 4,061,000 | 3,187,000 | 1,536,036 | 1,375,149 | 3,210,807 | 747,762 | 817,312 | 705,377 | 262,756 | 353,878 | 271,489 | 235,106 | 679,533 | 801,861 | 743,786 | 1,031,879 | 1,160,667 | 1,276,026 | 1,215,441 | 978,935 | 917,633 |
trade receivables and other assets | 10,688 | 14,953 | 16,900 | 9,395 | 7,892 | 11,419,000 | 11,154,000 | 12,506,000 | 23,123,000 | 15,909,000 | 9,573,000 | ||||||||||||||||||||||||||||
total current assets | 34,591 | 40,878 | 45,268 | 35,759 | 32,040 | 42,335,000 | 33,071,000 | 36,958,000 | 53,607,000 | 51,053,000 | 82,445,000 | 73,254,000 | 65,812,000 | 70,286,000 | 73,003,000 | 74,625,000 | 78,635,000 | 86,477,000 | 88,864,000 | 88,258,000 | 95,249,806 | 11,026,025 | 8,225,507 | 8,248,700 | 10,506,430 | 11,546,327 | 6,920,944 | 6,590,531 | 3,242,063 | 6,588,516 | 4,536,241 | 6,123,780 | 8,085,140 | 12,155,623 | 14,317,063 | 15,669,700 | 22,223,271 | 28,585,120 | 36,770,100 |
restricted cash | 144 | 144 | 144 | 144 | 144 | 581,000 | 985,000 | 4,346,000 | 2,536,000 | 3,329,000 | 2,593,000 | 4,032,000 | 1,805,000 | 574,000 | 1,469,000 | 3,573,000 | 5,068,000 | 4,173,000 | 4,895,000 | 2,777,000 | 618,525 | 333,829 | 416,594 | 232,409 | 242,037 | 249,288 | 359,172 | 255,361 | 251,965 | 269,770 | 227,707 | 232,869 | 230,144 | 204,615 | 429,100 | 470,193 | 137,779 | 310,458 | 56,510 |
investment in slm california | 60,437 | 61,189 | 61,617 | ||||||||||||||||||||||||||||||||||||
royalty and other property interests | 48,887 | 49,935 | 42,361 | 44,499 | 45,787 | 50,126,000 | 51,816,000 | 52,659,000 | 75,655,000 | 82,291,000 | 81,731,000 | 16,500,000 | 16,888,000 | 17,955,000 | 19,114,000 | 19,506,000 | |||||||||||||||||||||||
property and equipment | 625 | 791 | 742 | 770 | 810 | 885,000 | 929,000 | 1,259,000 | 1,576,000 | 1,467,000 | 859,000 | 852,000 | 863,000 | 759,000 | 755,000 | 641,000 | 634,000 | 644,000 | 622,000 | 488,000 | 465,539 | 469,574 | 448,711 | 458,906 | 436,401 | 440,635 | 471,704 | 501,992 | 538,003 | 614,460 | 668,317 | 715,472 | 751,229 | 850,322 | 1,038,792 | 1,321,388 | 1,517,940 | 1,643,178 | 1,391,124 |
deferred charges | 453 | 429 | 801 | ||||||||||||||||||||||||||||||||||||
total non-current assets | 112,244 | 115,466 | 111,246 | 120,327 | 125,325 | 126,819,000 | 129,776,000 | 129,446,000 | 182,990,000 | 177,637,000 | 149,020,000 | 72,376,000 | 32,517,000 | 30,334,000 | 31,862,000 | 32,736,000 | 30,693,000 | 18,816,000 | 18,876,000 | 21,185,000 | 19,601,716 | 35,644,616 | 35,831,616 | 37,528,255 | 39,009,452 | 40,589,624 | 40,922,611 | 41,473,806 | 39,864,236 | 44,035,613 | 46,796,066 | 48,846,197 | 46,206,953 | 53,037,444 | 54,597,251 | 58,364,112 | 58,024,464 | 9,680,031 | |
total assets | 146,835 | 156,344 | 156,514 | 156,086 | 157,365 | 169,154,000 | 162,847,000 | 166,404,000 | 236,597,000 | 228,690,000 | 231,465,000 | 145,630,000 | 98,329,000 | 100,620,000 | 104,865,000 | 107,361,000 | 109,328,000 | 105,293,000 | 107,740,000 | 109,443,000 | 114,851,522 | 46,670,641 | 44,057,123 | 45,776,955 | 49,515,882 | 52,135,951 | 47,843,555 | 48,064,337 | 43,106,299 | 50,624,129 | 51,332,307 | 54,969,977 | 54,292,093 | 65,193,067 | 69,621,115 | 70,266,951 | 80,587,383 | 86,609,584 | 46,450,131 |
liabilities | |||||||||||||||||||||||||||||||||||||||
accounts payable and accrued liabilities | 3,158 | 3,882 | 2,017 | 2,358 | 2,904 | 1,837,000 | 1,888,000 | 2,843,000 | 3,241,000 | 1,673,000 | 4,096,000 | 2,184,000 | 1,767,000 | 5,530,000 | 2,031,000 | 1,810,000 | 1,392,000 | 909,000 | 696,000 | 618,000 | 5,731,161 | 548,469 | 1,014,398 | 762,943 | 548,637 | 704,633 | 577,265 | 564,892 | 494,957 | 663,582 | 489,382 | 702,552 | 559,049 | 523,460 | 800,310 | 1,057,356 | 1,442,494 | 1,134,174 | 911,772 |
advances from joint venture partners | 217 | 307 | 865 | 1,318 | 1,378 | 775,000 | 1,381,000 | 1,359,000 | 3,392,000 | 4,128,000 | 3,633,000 | 3,047,000 | 2,985,000 | 1,304,000 | 1,913,000 | 4,295,000 | 5,815,000 | 4,290,000 | 5,011,000 | 2,739,000 | 615,669 | 371,740 | 453,824 | 176,201 | 183,977 | 292,575 | 341,361 | 130,461 | 128,622 | 137,825 | 151,059 | 217,496 | 429,175 | 213,061 | 649,885 | 297,473 | 366,842 | 289,751 | 373,674 |
derivative liabilities | 1,028 | 587 | 561 | 834 | 776 | 1,349,000 | 1,720,000 | ||||||||||||||||||||||||||||||||
total current liabilities | 4,403 | 4,776 | 3,443 | 38,180 | 38,262 | 7,139,000 | 8,186,000 | 9,252,000 | 10,988,000 | 9,765,000 | 21,939,000 | 6,346,830 | 7,372,721 | 1,468,222 | 939,144 | 732,614 | 997,208 | 918,626 | 695,353 | 623,579 | 801,407 | 640,441 | 920,048 | 988,224 | 736,521 | 1,450,195 | 1,354,829 | 1,927,991 | 1,423,925 | ||||||||||
loan payable | 24,622 | 34,570 | 34,774 | 33,670 | 33,204 | 3,178,000 | 3,178,000 | 3,178,000 | 50,606,000 | 3,964,000 | 45,016,000 | 54,134,000 | |||||||||||||||||||||||||||
deferred income tax liability | 1,761 | 1,669 | 888 | 826 | 661 | 4,543,000 | 2,653,000 | 1,099,000 | 1,472,000 | 1,204,000 | 1,408,000 | 1,447,012 | 1,490,180 | 3,405,249 | 4,491,414 | 4,642,744 | 4,753,324 | 4,962,897 | 5,364,230 | 6,501,886 | 7,976,375 | 8,645,488 | 8,217,542 | 10,471,746 | 10,384,220 | 12,306,728 | 12,839,822 | ||||||||||||
total non-current liabilities | 26,383 | 36,239 | 35,662 | 826 | 661 | 43,292,000 | 40,903,000 | 38,870,000 | 52,078,000 | 48,279,000 | 46,424,000 | ||||||||||||||||||||||||||||
total liabilities | 30,786 | 41,015 | 39,105 | 39,006 | 38,923 | 50,431,000 | 49,089,000 | 48,122,000 | 63,066,000 | 58,044,000 | 68,363,000 | 59,365,000 | 4,752,000 | 6,834,000 | 3,944,000 | 6,105,000 | 7,207,000 | 5,199,000 | 5,707,000 | 3,357,000 | 6,346,830 | 8,819,733 | 2,958,402 | 4,344,393 | 5,224,028 | 5,639,952 | 5,671,950 | 5,658,250 | 5,987,809 | 7,303,293 | 8,616,816 | 9,565,536 | 9,205,766 | 11,208,267 | 12,520,610 | 11,739,049 | 14,234,719 | 14,263,747 | 1,285,446 |
shareholders' equity | |||||||||||||||||||||||||||||||||||||||
capital stock | 159,451 | 157,143 | 163,636 | 164,845 | 160,958 | 160,861,000 | 157,979,000 | 157,875,000 | 213,582,000 | 211,742,000 | 200,257,000 | 136,718,000 | 134,877,000 | 133,394,000 | 131,678,000 | 130,427,000 | 129,427,000 | 128,330,000 | 127,972,000 | 126,124,000 | 125,231,209 | 124,148,295 | 124,085,916 | 123,869,568 | 123,843,019 | 117,635,830 | 117,504,585 | 117,445,810 | 117,334,492 | 117,000,052 | 116,943,352 | 116,823,702 | 116,766,102 | 116,376,525 | 116,209,275 | 115,460,469 | 114,877,815 | 113,698,908 | 80,520,395 |
reserves | 17,082 | 19,312 | 17,941 | 17,582 | 18,809 | 18,334,000 | 18,692,000 | 18,598,000 | 48,820,000 | 31,429,000 | 31,245,000 | 30,613,000 | 28,900,000 | 27,014,000 | 26,661,000 | 27,334,000 | 25,918,000 | 25,208,000 | 25,114,000 | 24,274,000 | 24,797,941 | 22,966,474 | 22,578,452 | 21,623,047 | 21,611,156 | 21,373,183 | 21,656,380 | 19,363,070 | 18,918,983 | 20,487,524 | 18,118,965 | 18,373,028 | 15,443,247 | 12,001,360 | 12,485,842 | 9,760,058 | 9,796,656 | 8,002,061 | |
deficit | -60,484 | -61,126 | -64,153 | -65,347 | -61,325 | -60,472,000 | |||||||||||||||||||||||||||||||||
total shareholders' equity | 116,049 | 115,329 | 117,409 | 117,080 | 118,442 | 118,723,000 | 113,758,000 | 118,282,000 | 173,531,000 | 170,646,000 | 163,102,000 | 86,265,000 | 93,577,000 | 93,786,000 | 100,921,000 | 101,256,000 | 102,121,000 | 100,094,000 | 102,033,000 | 106,086,000 | 108,504,692 | 37,850,908 | 41,098,721 | 41,432,562 | 44,291,854 | 46,495,999 | 42,171,605 | 42,406,087 | 37,118,490 | 43,320,836 | 42,715,491 | 45,404,441 | 45,086,327 | 53,984,800 | 57,100,505 | 58,527,902 | 66,352,664 | 72,345,837 | 45,164,685 |
total liabilities and shareholders' equity | 146,835 | 156,344 | 156,514 | 156,086 | 157,365 | 169,154,000 | 162,847,000 | 166,404,000 | 236,597,000 | 228,690,000 | 231,465,000 | 145,630,000 | 98,329,000 | 100,620,000 | 104,865,000 | 107,361,000 | 109,328,000 | 105,293,000 | 107,740,000 | 109,443,000 | 114,851,522 | 46,670,641 | 44,057,123 | 45,776,955 | 49,515,882 | 52,135,951 | 47,843,555 | 48,064,337 | 43,106,299 | 50,624,129 | 51,332,307 | 54,969,977 | 54,292,093 | 65,193,067 | 69,621,115 | 70,266,951 | 80,587,383 | 86,609,584 | 46,450,131 |
treasury stock | -15 | ||||||||||||||||||||||||||||||||||||||
investment in associated entity | 62,288 | 62,732 | 59,601,000 | 60,609,000 | |||||||||||||||||||||||||||||||||||
deferred financing charges | 464 | 439 | 389,000 | 398,000 | 389,000 | 518,000 | 481,000 | 461,000 | 408,000 | 310,000 | 81,000 | ||||||||||||||||||||||||||||
current | |||||||||||||||||||||||||||||||||||||||
cash | 21,587,000 | 9,980,000 | 9,089,000 | ||||||||||||||||||||||||||||||||||||
loan receivable | 269,000 | 761,000 | 750,000 | 1,370,000 | 2,501,000 | 2,542,000 | 510,000 | ||||||||||||||||||||||||||||||||
non-current | |||||||||||||||||||||||||||||||||||||||
assets held for sale | 655,000 | ||||||||||||||||||||||||||||||||||||||
liabilities associated with assets held for sale | 19,000 | ||||||||||||||||||||||||||||||||||||||
investments in associated entities | 58,206,000 | 80,315,000 | 69,544,000 | 42,202,000 | 47,849,000 | ||||||||||||||||||||||||||||||||||
derivative liability | 1,872,000 | ||||||||||||||||||||||||||||||||||||||
deferred income tax asset | 2,071,000 | 2,034,000 | 1,971,000 | 1,747,000 | 1,771,000 | 1,731,000 | 1,604,038 | ||||||||||||||||||||||||||||||||
loans payable | 4,355,000 | 14,210,000 | |||||||||||||||||||||||||||||||||||||
trade and settlement receivables, and other assets | 3,004,000 | 2,484,000 | 3,743,000 | 1,808,000 | 1,737,000 | 1,670,000 | 4,272,000 | 7,195,000 | 7,506,316 | ||||||||||||||||||||||||||||||
prepaid expenses | 523,000 | 518,000 | 539,000 | 359,000 | 664,000 | 459,000 | 112,000 | 164,000 | 126,000 | 32,123 | 98,106 | 141,410 | 84,095 | 95,387 | 129,174 | 28,496 | 81,540 | 105,909 | 32,344 | 123,849 | 152,056 | 52,209 | 121,846 | 169,737 | 184,866 | 108,744 | 272,999 | 114,930 | |||||||||||
strategic investments | 5,070,000 | 4,747,000 | 4,224,000 | 9,084,000 | 9,636,000 | 9,636,000 | 49,000 | 65,000 | 49,000 | 32,738 | 49,107 | 114,583 | 570,148 | 130,952 | 163,691 | 212,798 | 261,905 | 261,905 | 193,810 | 458,095 | 317,143 | 299,524 | |||||||||||||||||
reclamation bonds | 1,062,000 | 1,008,000 | 910,000 | 642,000 | 723,000 | 786,000 | 431,000 | 425,000 | 434,000 | 443,599 | 538,698 | 529,504 | 504,636 | 522,943 | 638,512 | 639,427 | 528,091 | 606,401 | 810,734 | 871,506 | 938,221 | 823,447 | 816,449 | 872,041 | 713,602 | 721,540 | 470,751 | 491,239 | |||||||||||
deferred acquisition costs | 452,000 | ||||||||||||||||||||||||||||||||||||||
investment in associate | 8,520,000 | 6,224,000 | |||||||||||||||||||||||||||||||||||||
loans receivable | 490,000 | 881,000 | 863,000 | ||||||||||||||||||||||||||||||||||||
nature of operations and going concern | |||||||||||||||||||||||||||||||||||||||
exploration and evaluation assets | 1,313,000 | 1,480,000 | 1,480,000 | 1,480,000 | 1,612,901 | 1,711,210 | 1,711,210 | 2,039,900 | 2,039,900 | 2,039,900 | 2,145,000 | 2,145,000 | 2,276,440 | 2,381,540 | 2,420,311 | 2,472,861 | 2,379,886 | 3,031,368 | 3,031,368 | 3,743,104 | 4,993,266 | 4,940,941 | 6,137,230 | ||||||||||||||||
royalty interest | 16,149,000 | 13,760,000 | 13,823,000 | 13,737,000 | 14,346,403 | 22,095,391 | 22,109,399 | 22,639,248 | 24,118,965 | 25,239,737 | 25,831,152 | 25,973,977 | 26,289,089 | 28,798,980 | 30,355,148 | 31,520,535 | 29,327,960 | 34,268,158 | 35,861,581 | 34,186,700 | 39,011,026 | 38,976,295 | |||||||||||||||||
note receivable | 514,000 | 502,000 | 490,000 | 477,973 | |||||||||||||||||||||||||||||||||||
events subsequent to the reporting date | |||||||||||||||||||||||||||||||||||||||
investment in an associated company | 8,457,338 | ||||||||||||||||||||||||||||||||||||||
goodwill | 1,447,012 | 1,490,180 | 3,405,249 | 4,491,414 | 4,642,744 | 4,753,324 | 4,962,897 | 5,364,230 | 6,501,886 | 7,976,375 | 8,645,488 | 8,217,542 | 9,596,092 | 9,953,436 | 9,270,250 | 9,155,030 | 9,240,889 | ||||||||||||||||||||||
other assets | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 104,484 | 146,604 | 159,062 | 159,062 | 159,062 | ||||||||||||||||||||||
commitment to issue shares | 6,111,658 | 139,138 | 223,607 | 297,747 | 306,999 | 551,107 | 554,893 | 1,149,027 | 910,623 | 376,292 | 679,165 | ||||||||||||||||||||||||||||
trade and settlement receivables | 2,632,903 | 2,620,154 | |||||||||||||||||||||||||||||||||||||
notes receivable | 437,973 | 433,973 | 893,006 | 913,648 | 862,316 | ||||||||||||||||||||||||||||||||||
promissory note | 6,452,512 | ||||||||||||||||||||||||||||||||||||||
investment in associated companies | 8,472,978 | 5,897,066 | 5,216,480 | 4,802,206 | 4,992,823 | 2,835,691 | 3,333,491 | 3,714,123 | 3,899,124 | 4,072,737 | 3,461,194 | 3,688,250 | 4,465,410 | 2,668,469 | 2,282,890 | 1,444,866 | |||||||||||||||||||||||
receivables | 2,284,552 | 3,299,986 | 2,557,609 | 3,430,006 | 2,367,497 | 482,708 | 686,465 | 1,606,798 | 1,109,915 | 838,837 | 1,313,245 | 1,568,975 | 1,071,698 | 961,971 | 1,205,330 | 1,025,009 | |||||||||||||||||||||||
convertible notes receivable | 1,336,028 | 1,026,458 | |||||||||||||||||||||||||||||||||||||
investment in associated company | 4,413,609 | ||||||||||||||||||||||||||||||||||||||
othe rassets | 104,484 | ||||||||||||||||||||||||||||||||||||||
total non-currentassets | 55,304,052 | ||||||||||||||||||||||||||||||||||||||
deferred incom etaxliability | 11,070,415 | ||||||||||||||||||||||||||||||||||||||
income taxes payable | 118,655 | ||||||||||||||||||||||||||||||||||||||
share based payment reserve | 7,146,549 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
cash flows from operating activities | |||||
income for the period | 642 | 1,260 | |||
items not affecting operating activities: | |||||
interest income | -188 | -374 | -533 | -430 | -448 |
effect of exchange rate changes on cash and cash equivalents | 34 | -30 | -145 | 39 | 112 |
items not affecting cash: | |||||
gain on revaluation of investments | -720 | -746 | -1,142 | -84 | |
equity income from investment in slm california | -1,334 | -1,680 | |||
share-based payments | 464 | 1,227 | 359 | 1,354 | 189 |
deferred income tax expense | 93 | 83 | 62 | 165 | -155 |
depletion and depreciation | 972 | 2,319 | 2,194 | 1,326 | 2,417 |
finance expense | 516 | 681 | 921 | 1,080 | 1,065 |
shares received pursuant to property agreements | -42 | -51 | -32 | -60 | 9 |
other non-cash movements | 1,247 | 298 | -22 | 1,318 | 502 |
changes in non-cash working capital items | 5,208 | -1,698 | -1,899 | 1,269 | 399 |
total cash from operating activities | 6,892 | 1,289 | -187 | -514 | 1,027 |
cash flows from investing activities | |||||
dividends and other distributions | 2,086 | 1,617 | 1,995 | 1,900 | 1,679 |
acquisition of royalty and other property interests | -564 | -7,532 | |||
purchase of investment in slm california | |||||
proceeds from sale of fair value through profit and loss investments | 301 | 85 | |||
other movements | 102 | 14 | -162 | 92 | 45 |
total cash from investing activities | 1,925 | -5,816 | 2,076 | 2,507 | -2,174 |
cash flows from financing activities | |||||
loan repayments | -33,433 | -614 | -613 | ||
interest paid | -496 | -660 | |||
purchase of common shares returned to treasury | -2,554 | -2,442 | -1,224 | ||
proceeds from exercise of options and settlement of rsus | 2,210 | 41 | 0 | ||
deferred financing costs | |||||
total cash from financing activities | -10,840 | -3,061 | -613 | ||
change in cash and cash equivalents | -2,057 | -7,558 | 252 | 2,616 | -1,872 |
cash and cash equivalents, beginning | 0 | 26,773 | 0 | 0 | 20,677 |
cash and cash equivalents, ending | -2,057 | 19,215 | 252 | 2,616 | 18,805 |
loss for the period | 1,194 | -4,022 | -2,227 | ||
(gain) loss on revaluation of investments | |||||
equity income from investments in associate | -1,276 | -1,411 | -797 | ||
loss on debt settlement | |||||
impairment charges | 0 | 0 | 45 | ||
purchase of investment in associated entity | 0 | 0 | -4,742 | ||
proceeds from franco-nevada loan | |||||
financing costs | |||||
loan receivable | |||||
proceeds from the sale of fair value through profit and loss investments | 515 | 844 | |||
total cash from (used) in financing activities | |||||
cash in assets held for sale | |||||
cash flows used in investing activities | |||||
increase in cash held in trust | |||||
change in fair value of fair value through profit or loss assets | |||||
equity income from investments in associates | |||||
bonus shares issued | |||||
gain on debt modification | |||||
income tax recovery | |||||
depreciation | |||||
depletion | |||||
finance charges, net of settlement gains | |||||
realized (gain) loss on sale of investments | |||||
unrealized foreign exchange loss | |||||
option payments received | |||||
interest received on cash and cash equivalents | |||||
loan interest received | |||||
proceeds from loan repayment | |||||
deferred acquisition costs | |||||
purchases of fair value through profit and loss investments | |||||
purchase of royalty interests | |||||
purchase and sale of property and equipment | |||||
reclamation bonds | |||||
loans payable | |||||
proceeds from private placement | |||||
share issue costs | |||||
proceeds from exercise of options | |||||
income for the year | |||||
interest income received | |||||
unrealized foreign exchange effect on cash and cash equivalents | |||||
change in fair value of fair value throught profit or loss assets | |||||
interest and finance charges, net of settlement gains | |||||
share - based payments | |||||
deferred income tax recovery | |||||
impairment of royalty interest | |||||
writedown of goodwill | |||||
gain on acquisition and sale of exploration and evaluation assets, net of derecognition of equipment | |||||
gains in an associated company, net of dilution gains and loss on derecognition | |||||
shares received from operating partners included in exploration recoveries | |||||
unrealized foreign exchange (gain) loss | |||||
acquisition and sale of exploration and evaluation assets, net of option payments received | |||||
distributions from investments | |||||
proceeds from credit facility and loan repayments received | |||||
repayment of credit facility and loan distributions | |||||
notes receivable | |||||
proceeds from sale of fair value through profit and loss investments, | |||||
proceeds on available for sale financial instruments | |||||
purchase of investments in associated companies | |||||
restricted cash | |||||
proceeds from sprott facility | |||||
repayment of sprott credit facility | |||||
proceeds received from private placement, net of share issue costs | |||||
loss for the year | |||||
change in fair value of fair value throught profit or loss investments | |||||
commitment to issue shares | |||||
bonus shares issued as performance bonuses | |||||
interest on convertible loan | |||||
write down of goodwill | |||||
impairment of receivables | |||||
realized loss on sale of investments | |||||
gain on acquisition and sale of exploration and evaluation assets | |||||
gain | |||||
write-off of exploration and evaluation assets | |||||
write-off other assets | |||||
equity loss in associated companies | |||||
shares received from joint venture partners included in exploration recoveries | |||||
changes in non-cash working capital items: | |||||
receivables | |||||
prepaid expenses | |||||
accounts payable and accrued liabilities | |||||
advances from joint venture partners | |||||
acquisition and sale of exploration and evaluation assets, net option payments received | |||||
convertible note receivable | |||||
purchase of available-for-sale financial instruments | |||||
purchase of royalty interest | |||||
proceeds from option exercised | |||||
balance as at december 31, 2014 | |||||
shares issued as incentive stock grants | |||||
equity investment share-based payments | |||||
foreign currency translation adjustment | |||||
change in fair value of financial instruments | |||||
balance as at december 31, 2015 | |||||
change in fair value of fair value through profit or loss investments | |||||
commitment to issue bonus shares | |||||
deferred income taxr ecovery | |||||
income tax expense | |||||
fair value of stock options granted | |||||
loss on derecognition and sale o fproperty and equipment | |||||
derecognition of property and equipment on sale of exploration and evaluation assets | |||||
loss on sale of foreign licenses and permits | |||||
write-off of other assets | |||||
income taxes payable | |||||
cashflows from investing activities | |||||
acquisition of exploration and evaluation assets, net option payments received | |||||
acquisition of bullion monarch | |||||
cash acquired in acquisition of bullion monarch | |||||
proceeds from saleof other assets | |||||
purchase and sale of fair value through profit and loss investments | |||||
total cash provided used in investing activities | |||||
proceeds fromoptions exercised | |||||
proceeds from warrants exercised | |||||
effec tof exchange rate changes on cash and cash equivalents | |||||
balanceas at december 31, 2013 | |||||
shares issued as bonus shares |